In today's world, Methitural is a relevant topic that impacts people of all ages, genders, and backgrounds. The importance of addressing this issue lies in its influence on different aspects of daily life, from physical and emotional health to social and economic development. Throughout history, Methitural has been the subject of extensive research and debate, giving rise to a wide range of perspectives and approaches on how to approach it. In this article, we will explore different aspects of Methitural, from its origins to its implications today, in order to provide a comprehensive and up-to-date view on this topic.
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C12H20N2O2S2 |
Molar mass | 288.42 g·mol−1 |
3D model (JSmol) | |
| |
|
Methitural (INN; Neraval, Thiogenal), or methitural sodium, also known as methioturiate, is a barbiturate derivative which was marketed in the 1950s in Europe (in Germany and Italy) as an ultra-short-acting intravenous anesthetic.
A somewhat more complex side chain is incorporated by alkylation of the carbanion of the substituted cyanoacetate (1) with 2-chloroethylmethyl sulfide (2). Condensation of the resulting cyanoester (3) with thiourea followed by hydrolysis of the resulting imine affords methitural.